Anheuser-Busch InBev Q1 EPS $0.51 Beats $0.50 Estimate

Vascular Biogenics (NASDAQ:VBLT) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.11) by 18.18 percent. This is a 8.33 percent decrease over losses of $(0.12) per share